Thomas Jefferson University
Sidney Kimmel Medical College
Department of Medicine

Summer, Ross

< Back


Ross Summer, MD

Ross Summer, MD

Contact Dr. Summer

834 Walnut Street
Suite 650
Philadelphia, PA 19107

(215) 955-5161
(215) 955-0830 fax

Medical School

Louisiana State University - New Orleans - 1996


Johns Hopkins University Hospital


Boston University Medical Center Hospital

Board Certification

Critical Care Medicine
Pulmonary Disease
Internal Medicine

Hospital Appointment

Thomas Jefferson University Hospital

University Appointment

Professor of Medicine
Chief of Section of Allergy, Pulmonary and Critical Care Medicine

Research & Clinical Interests

Dr Ross Summer is a board certified pulmonary and critical care physician and an NIH-funded investigator. Dr Summer completed his residency training in Internal Medicine at Johns Hopkins Hospital in Baltimore, Maryland and then went on to complete a four-year pulmonary and critical care fellowship at Boston University. Dr Summer spends his time attending on the pulmonary consult service and in the medical intensive care unit at Thomas Jefferson in center city Philadelphia. In addition, Dr Summer spends a significant portion of his time overseeing a basic science program whose major focus is to understand the molecular mechanisms contributing to the pathogenesis of Acute Respiratory Distress syndrome (ARDS) and Idiopathic Pulmonary Fibrosis (IPF).


Most Recent Peer-Reviewed Publications

  1. Hermansky-Pudlak syndrome-2 alters mitochondrial homeostasis in the alveolar epithelium of the lung
  2. Tocilizumab in the Management of COVID-19: A Preliminary Report
  3. Acute Exacerbation of Interstitial Lung Disease as a Sequela of COVID-19 Pneumonia
  4. On Race and the Environment in the COVID-19 Pandemic
  5. COVID-19 Retesting in the Primary Care Setting
  6. Retraction: Obesity-induced endoplasmic reticulum stress causes lung endothelial dysfunction and promotes acute lung injury
  7. A Comprehensive Review of Manifestations of Novel Coronaviruses in the Context of Deadly COVID-19 Global Pandemic
  8. E-cigarettes and Vaping Associated Lung Injury: A Case Series and Brief Review
  9. Alcohol-induced lipid dysregulation impairs glycolytic responses to LPS in alveolar macrophages
  10. Maxed out on glycolysis: Alveolar macrophages rely on oxidative phosphorylation for cytokine production
  11. Pulmonary circulation in obesity, diabetes, and metabolic syndrome
  12. The histone deacetylase inhibitor tubacin mitigates endothelial dysfunction by up-regulating the expression of endothelial nitric oxide synthase
  13. Lipid Uptake by Alveolar Macrophages Drives Fibrotic Responses to Silica Dust
  14. The involvement of GM-CSF deficiencies in parallel pathways of pulmonary alveolar proteinosis and the alcoholic lung
  15. Matrix metalloproteinase activity in the lung is increased in Hermansky-Pudlak syndrome
  16. Time to personalize the treatment of anti-MDA-5 associated lung disease
  17. Activation of the mTORC1/PGC-1 axis promotes mitochondrial biogenesis and induces cellular senescence in the lung epithelium
  18. Metabolic Reprogramming as a Driver of Fibroblast Activation in PulmonaryFibrosis
  19. Proteomic profile of TGF-β1 treated lung fibroblasts identifies novel markers of activated fibroblasts in the silica exposed rat lung
  20. Cellular Metabolism in Lung Health and Disease
  21. Fine-tuning the ubiquitin-proteasome system to treat pulmonary fibrosis
  22. Lipid metabolism: A new player in the conundrum of lung fibrosis
  23. Activated fibroblasts: Gluttonous for glutamine
  24. Combination of biochanin a and temozolomide impairs tumor growth by modulating cell metabolism in glioblastoma multiforme
  25. Nur77 limits endothelial barrier disruption to LPS in the mouse lung